scispace - formally typeset
G

Gerald Yong

Researcher at Fiona Stanley Hospital

Publications -  44
Citations -  1550

Gerald Yong is an academic researcher from Fiona Stanley Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 17, co-authored 37 publications receiving 1310 citations. Previous affiliations of Gerald Yong include Sir Charles Gairdner Hospital & Royal Perth Hospital.

Papers
More filters
Journal ArticleDOI

Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis

TL;DR: In this article, the authors compared the procedural and clinical outcomes in patients with bicuspid versus tricusid aortic valve stenosis (AS) from the BICUSID AS TAVR multicenter registry.
Journal ArticleDOI

Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.

TL;DR: New-generation devices were associated with less paravalvular leak and, hence, a higher device success rate than early- Generation devices, and the clinical outcomes of TAVR in patients with bicuspid AS were favorable.
Journal ArticleDOI

Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience.

TL;DR: The preliminary data suggested LAA closure with ACP is safe, feasible with encouraging 1‐yr clinical outcomes, and further large‐scaled trials are needed to confirm the efficacy of this device.
Journal ArticleDOI

Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study.

TL;DR: TAVR using the next-generation THV is clinically safe and effective for treating older patients with severe AS at increased operative risk.
Journal ArticleDOI

Outcome of patients after transcatheter aortic valve embolization.

TL;DR: Clinical outcomes remain good when THV embolization is managed effectively and there are no apparent hemodynamic consequences of a second valve placed in the series after TAVI.